Sign in

CIK 0001806952

  • Non-accelerated filer
  • Smaller reporting company

Lyell Immunopharma, Inc.

Sign in to watch
Ticker
LYEL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
833006753
Phone
+1 650-695-0677
Business address
201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market buy Director bought 35,640 shares at $0.56 ($19,958)
  2. 4 Open-market buy Director bought 200,000 shares at $0.58 ($115,220)
  3. 4 Open-market buy Director bought 158,000 shares at $0.60 ($94,942)
  4. 4 Open-market buy Chief Financial Officer bought 200,000 shares at $0.56 ($111,620)
  5. 4 Open-market buy President and CEO bought 175,000 shares at $0.61 ($106,190)
  6. 4 Grant or award Chief Business Officer acquired 112,500 shares (grant or award)
  7. 4 Grant or award President and CEO acquired 337,500 shares (grant or award)
  8. 4 Grant or award Chief Operating Officer acquired 112,500 shares (grant or award)
  9. 4 Grant or award Chief Financial Officer acquired 112,500 shares (grant or award)
  10. 4 Grant or award Chief Scientific Officer acquired 112,500 shares (grant or award)
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Grant or award Chief Business Officer acquired 50,000 shares (grant or award)

Page 5 of 9 · 173 filings